Funding for this research was provided by:
Julius-Maximilians-Universität Würzburg
Article History
Received: 29 April 2020
Accepted: 25 August 2020
First Online: 2 September 2020
Compliance with ethical standards
:
: FG reports personal fees from Abbvie, Alexion, and Lilly. LS reports personal fees from Abbvie, Amgen, Alexion, KyowaKirin, Lilly, Medi, MSD, Novartis, Servier, and UCB and research grants to the Institution (University of Wuerzburg) from Alexion, Kyowa Kirin, and Novartis. LC and DR have nothing to disclose during the study course.
: The study protocol was approved by the competent ethics committee at Wuerzburg University (Nr. 20180105 01).
: n.a. (retrospective chart review)